Technology Networks

TGFβ Inhibition Improves Disease Markers in Rare "Butterfly Skin" Condition

Researchers are developing a pipeline of preclinical models for epidermolysis bullosa, which could be used by academics and ...
Tech Times

Mild COVID Triggers Eye Nerve Damage That Standard Exams Fail to Detect

Post-COVID eye nerve damage leaves millions with corneal nerve loss and pupillary dysfunction that standard exams cannot ...
The Manila Times

InxMed Announces Publication in The Lancet Respiratory Medicine Featuring Promising Anticancer Activity of Ifebemtinib in combination with Garsorasib in First-Line non-small ...

InxMed Co., Ltd ('InxMed'), a clinical-stage biotechnology company dedicated to developing innovative therapies targeting cancer treatment resistance and metastasis, today announced that the clinical ...
Lupus Science & Medicine

Upadacitinib enhances platelet procoagulant responses in a subset of healthy individuals and patients with SLE: a pilot study

Background Janus kinase inhibitors (JAKis) are emerging therapies for SLE, but concerns regarding thromboembolic risk persist ...
Queen Mary University of London

Major step forward as new approach to rare disease drug development yields first research results.

The TREAT-EB collaboration between Queen Mary University of London and DEBRA Research aims to circumvent the discovery ...